Clovis Oncology Inc (CLVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLVS | AZN | AMGN | GILD | VRTX |
| Company | Clovis Oncology Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.0808 | 89.40 | 317.30 | 122.86 | 444.81 |
| High | 0.0977 | 89.89 | 319.28 | 123.63 | 453.05 |
| Low | 0.0766 | 89.28 | 316.07 | 122.12 | 444.81 |
| Latest | 0.0812 | 89.73 | 318.86 | 122.88 | 453.69 |
| Change | -0.0048 | -0.56 | +1.48 | -0.33 | +7.76 |
| % Change | -5.58% | -0.62% | +0.47% | -0.27% | +1.74% |
| Volume | 24,516,400 | 963,475 | 218,027 | 551,120 | 97,329 |
| 20-Day Average Volume | 9,433,500 | 5,447,271 | 2,749,227 | 6,720,872 | 1,310,145 |
| Previous Close | 0.0860 | 90.29 | 317.38 | 123.21 | 445.93 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.2340 | 90.59 | 334.03 | 124.34 | 437.48 |
| 20-Day Raw Stochastic | 1.73% | 24.76% | 14.95% | 41.56% | 66.73% |
| 20-Day Relative Strength | 23.83 | 54.99 | 47.59 | 51.45 | 58.15 |
| Weighted Alpha | -91.19 | +37.55 | +17.40 | +31.44 | +0.63 |
| Today's Opinion | 100% Sell | 88% Buy | 72% Buy | 72% Buy | 40% Buy |
| Previous Opinion | 100% Sell | 88% Buy | 72% Buy | 72% Buy | 40% Buy |
| Last Month's Opinion | 100% Sell | 100% Buy | 56% Buy | 100% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -39.04% since 12/13/22 | -0.53% since 12/05/25 | -3.77% since 12/05/25 | +1.39% since 12/05/25 | -1.47% since 12/05/25 |
| Low | 0.0760 on 12/16/22 | 89.35 on 12/12/25 | 312.39 on 12/11/25 | 118.78 on 12/10/25 | 433.81 on 12/10/25 |
| High | 0.1439 on 12/14/22 | 91.66 on 12/10/25 | 329.67 on 12/08/25 | 123.74 on 12/11/25 | 457.17 on 12/08/25 |
| 1-Month | |||||
| %Chg | -76.74% since 11/18/22 | +2.30% since 11/12/25 | -5.59% since 11/12/25 | -0.41% since 11/12/25 | +3.36% since 11/12/25 |
| Low | 0.0760 on 12/16/22 | 87.62 on 11/13/25 | 312.39 on 12/11/25 | 118.78 on 12/10/25 | 418.53 on 11/19/25 |
| High | 0.3772 on 12/01/22 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | -92.75% since 09/20/22 | +12.75% since 09/12/25 | +14.86% since 09/12/25 | +7.29% since 09/12/25 | +13.75% since 09/12/25 |
| Low | 0.0760 on 12/16/22 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 1.3100 on 10/04/22 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | -93.12% since 06/17/22 | +19.60% since 06/12/25 | +6.79% since 06/12/25 | +9.68% since 06/12/25 | -2.45% since 06/12/25 |
| Low | 0.0760 on 12/16/22 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 3.2500 on 07/08/22 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,770 | 280,027,776 | 170,903,104 | 152,864,192 | 113,140,912 |
| Shares Outstanding, K | 144,955 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 148,760,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -264,520,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 30,660,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -56,010,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 0.24 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.39 on 11/09/22 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 02/22/23 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.02 | 14.42 | 14.82 | 29.04 |